Isotonitazepyne Stats & Data

Identity and class: Isotonitazepyne (N-pyrrolidino isotonitazene) is a benzimidazole nitazene opioid; PubChem CID 168322631 confirms structure and identifiers. Counterfeit risk: Drug-checking programs have repeatedly detected isotonitazepyne/protonitazepyne in fake “oxycodone/percocet” tablets; assume any non‑pharmacy tablet may contain nitazenes. Market alerts: EU drug monitoring reports document rising nitazene involvement in poisonings and widespread appearance in fake medicines across multiple EU countries. Test strips: Standard fentanyl test strips do not detect nitazenes; rely on lab drug checking or nitazene-specific methods where available. Onset and redosing: Some nitazenes show a short but sometimes delayed onset; wait at least 10–15 minutes after an insufflated test dose before any redose to reduce stacking risk. Overdose response: Expect profound respiratory depression; multiple 2–4 mg intranasal naloxone doses at 2–5 min intervals may be required, and recurrent sedation can occur—call emergency services and monitor continuously. Polysubstance risk: Benzodiazepines, alcohol, barbiturates, Z‑drugs, GHB/GBL and gabapentinoids synergistically worsen CNS/respiratory depression; avoid mixing. Adulterant co-exposures: In current markets, opioids are frequently combined with veterinary sedatives (xylazine, medetomidine) and/or benzodiazepines, further increasing overdose risk. Dosing method: Active in double‑digit micrograms—use volumetric dosing (e.g., dissolve a known amount into a measured volume, label clearly, and use an oral or nasal metered syringe) to avoid lethal error; avoid handling loose powder and prevent cross‑contamination. Naloxone access: Carry take‑home naloxone; many EU countries and local services now provide it—seek training. Avoid smoking/vaping: Pyrolysis behavior and delivered dose are unpredictable for nitazenes; inhalation can cause rapid overdose—safer routes remain those allowing measured dosing (e.g., diluted nasal sprays). [inference from general high‑potency opioid handling and drug‑checking cautions]. Do not use alone: Use with a trusted, naloxone‑trained person present and avoid using in isolation; consider supervised consumption where available.